预测性分析老年患者的凝血功能障碍,由céfoperazone sodium-sulbactam sodium引起的使用
Man-Gui Li1, Yuan-Hong Zeng2, Cheng-Juan Xie1
1Department of Laboratory Medicine, Qinghai Red Cross Hospital, Xining, Qinhai, Gansu, China.
Annals of clinical and laboratory science
|September 17, 2025
概括
接受塞福拉-苏尔巴克坦治疗的老年患者可能会出现凝血障碍. 较高的年龄,较低的血小板数量和较高的肌素水平增加了这种风险,有助于早期检测.
科学领域:
- 药理学 药理学是指药理学的学科.
- 老年病的医生 老年病的医生
- 临床医学 临床医学
背景情况:
- 塞福拉-苏尔巴克坦在老年患者中被广泛使用.
- 凝血功能障碍是潜在的不良影响.
- 识别风险因素对于患者安全至关重要.
研究的目的:
- 为了确定影响老年患者凝血功能障碍的因素,用Cefoperazone-sulbactam治疗.
- 为临床药物选择提供安全参考.
主要方法:
- 对113名老年患者 (≥60岁) 进行了回顾性分析,这些患者接受了 cefoperazone-sulbactam治疗.
- 使用了后勤回归和ROC曲线分析.
- 分析的因素包括年龄,血小板数,肌素和肝/功能.
主要成果:
- 43.4%的患者出现了凝血障碍.
- 晚年,低血小板数和高肌素水平是显著的危险因素 (P<0.05).
- 综合指标显示了高的诊断疗效 (AUC=0.820).
结论:
- 年龄,血小板数量和肌水平是预测老年人中塞福拉-苏尔巴克坦诱导的凝血功能障碍的关键指标.
- 这些因素的综合评估可以提高诊断的准确性.
- 监测这些参数有助于早期诊断和管理.
相关概念视频
Drug Dosing: Geriatric Patients
228
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
228
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
238
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
238
Pharmacodynamics in Geriatric Patients: Effects of Age
188
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
188
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
197
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
197
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
229
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
229
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
232
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
232

